HOME >> BIOLOGY >> NEWS
Merck / AAAS announce 2005 winners for outstanding undergraduate research programs

WASHINGTON, DC- The Merck Company Foundation and the American Association for the Advancement of Science (AAAS) today announced winners of the 2005 awards for the Merck/AAAS Undergraduate Science Research Program.

This year's winners are Bowdoin College, Fairleigh Dickinson University, Furman University, Harvey Mudd College, Hope College, McNeese State University, North Central College, Northern Kentucky University, Oakland University, Otterbein College, Seattle University, St. Olaf College, University of the Sciences in Philadelphia, Ursinus College, and Vassar College.

The Merck/AAAS Undergraduate Science Research Program (USRP) is a national competitive awards program available in all 50 states, the District of Columbia, and Puerto Rico. Fifteen awards are made annually, and each award provides up to $60,000, paid over three years at $20,000 per year, for joint use by the biology and chemistry departments at each recipient institution. The funding supports research stipends for undergraduate students and ancillary programs that foster interactions between these departments.

Launched in 2000 as a national competition, awards will be made through 2009. This ten-year, $9 million initiative is funded by The Merck Company Foundation and administered by AAAS. The program goals are to:

  • enhance undergraduate education through research experiences that emphasize the interrelationship between chemistry and biology;
  • encourage students to pursue graduate education in chemistry and life sciences; and
  • foster undergraduate programs and activities that bridge chemistry and biology.

The program is open to qualified institutions in the United States and Puerto Rico that offer an American Chemical Society-certified program in chemistry and confer 10 or fewer graduate degrees annually in biology and chemistry combined. For additional information, send questions to merck@aaas.org
'"/>


17-Feb-2005


Page: 1 2

Related biology news :

1. Merck and AAAS announce 2007 winners of Outstanding Undergraduate Research Programs
2. Harvard Medical signs agreement with Merck to develop potential therapy for macular degeneration
3. Merck and AAAS announce 2006 winners for Outstanding Undergraduate Research Programs
4. Researchers gain support from Merck Sharp & Dohme for novel area of diabetes research
5. Nobel Laureate Sydney Brenner receives 2005 UCSD/Merck Life Science Achievement Award
6. Merck CEO Raymond Gilmartin to lecture at NJIT
7. Protein tyrosine phosphatases to be topic of ASBMB-Merck Award lecture
8. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
9. ESA announces 2007 award recipients
10. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology
11. 2007-2008 Genzyme/ACMGF Clinical Genetics Fellowship In Biochemical Genetics award winner announced

Post Your Comments:
(Date:10/15/2014)... an unexpected extent. The outbreak does not follow the ... a new disease dynamic in regions, where it has ... National Academy of Sciences Leopoldina, acatech – the German ... the German Academies of Sciences and Humanities have presented ... the statement the academies call for the following consequences ...
(Date:10/15/2014)... 15, 2014   Neurotechnology , a provider ... availability of the VeriLook Surveillance 3.0 software ... real-time biometric face identification using live video streams ... The new version not only identifies faces in ... objects while they are moving through the video ...
(Date:10/14/2014)... house fly genome for the first time, revealing robust ... that thrives in pathogen-rich dung piles and garbage heaps. ... Genome Biology , will increase understanding of house ... adapt to resist insecticides, which could lead to novel ... and transmit more than 100 human and animal diseases, ...
Breaking Biology News(10 mins):Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3House fly genome reveals expanded immune system 2
(Date:10/22/2014)... CA (PRWEB) October 22, 2014 ... from Sartorius, A & D Weighing, Rice Lake, ... CPA Semi-Micro Balance . The Sartorius CPA Semi-Micro ... an affordable high-quality, precise, and user-friendly laboratory balance. ... of laboratory equipment, their laboratory balances are well ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Physicians ... its cardiovascular pharmacogenetics menu, which enables healthcare providers ... With PCLS’s evidence-based results, healthcare providers are ... optimize their therapy, while minimizing risks for adverse ... U.S., according to the FDA [1] more than ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. (OTCQB: ... 400 million people worldwide are living with diabetes, with  ... by 2030.  The global market for diabetes treatments is ... 330,000 people worldwide died from pancreatic cancer.  Pancreatic cancer ... to cancer in the United States ...
Breaking Biology Technology:Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2
Cached News: